{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:02:21Z","timestamp":1787889741662,"version":"build-2784847793"},"reference-count":209,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pnpbp.2026.111722","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:59:53Z","timestamp":1777517993000},"page":"111722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Energy metabolic failure drives the selective degeneration of dopaminergic neurons in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"147","author":[{"given":"Zhipeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.pnpbp.2026.111722_bb0005","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mds.26605","article-title":"Neuropathological basis of nonmotor manifestations of parkinson\u2019s disease","volume":"31","author":"Adler","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0010","doi-asserted-by":"crossref","first-page":"1592511","DOI":"10.3389\/fphar.2025.1592511","article-title":"Cisplatin induces hippocampal neurotoxicity and cognitive impairment in rats through neuroinflammation, oxidative stress, and overexpression of glutamatergic receptors mRNA","volume":"16","author":"Alhowail","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0015","doi-asserted-by":"crossref","first-page":"15055","DOI":"10.1007\/s12035-025-05098-8","article-title":"The effect of metformin on astrocytes in parkinson\u2019s disease: challenges and opportunities","volume":"62","author":"Al-Kuraishy","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0020","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2174\/1570159X20666220830112408","article-title":"Mitochondrial medicine: a promising therapeutic option against various neurodegenerative disorders","volume":"21","author":"Almikhlafi","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","article-title":"Metformin role in parkinson\u2019s disease: a double-sword effect","volume":"479","author":"Alrouji","year":"2024","journal-title":"Mol. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0030","doi-asserted-by":"crossref","first-page":"15108","DOI":"10.1007\/s12035-025-05113-y","article-title":"Targeting of the PI3 K\/AKT\/GSK3\u03b2 pathway in parkinson\u2019s disease: a therapeutic blueprint","volume":"62","author":"AlRuwaili","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111722_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70721","article-title":"Differential roles of angiotensin a and alamandine in parkinson\u2019s disease: a therapeutic perspective on nonclassical RAS pathways","volume":"15","author":"Alshehri","year":"2025","journal-title":"Brain Behav."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0040","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1080\/15548627.2025.2457915","article-title":"Development and validation of a sensitive sandwich ELISA against human PINK1","volume":"21","author":"Baninameh","year":"2025","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051772","article-title":"PINK1\/parkin mediated mitophagy, ca(2+) signalling, and ER-mitochondria contacts in Parkinson\u2019s disease","volume":"21","author":"Barazzuol","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41419-024-06617-6","article-title":"Orthogonal analysis of mitochondrial function in Parkinson\u2019s disease patients","volume":"15","author":"Barnhoorn","year":"2024","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0055","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41590-022-01185-3","article-title":"Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation","volume":"23","author":"Billingham","year":"2022","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12974-018-1233-2","article-title":"The inhibitory effect of LPS on the expression of GPR81 lactate receptor in blood-brain barrier model in vitro","volume":"15","author":"Boitsova","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111722_bb0065","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/mds.25135","article-title":"Living on the edge with too many mouths to feed: why dopamine neurons die","volume":"27","author":"Bolam","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102698","article-title":"NOX4 as a critical effector mediating neuroinflammatory cytokines, myeloperoxidase and osteopontin, specifically in astrocytes in the hippocampus in Parkinson\u2019s disease","volume":"62","author":"Boonpraman","year":"2023","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JPD-201981","article-title":"Mitochondria and parkinson\u2019s disease: clinical, molecular, and translational aspects","volume":"11","author":"Borsche","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: a randomized phase i trial of nicotinamide riboside supplementation in Parkinson\u2019s disease","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metab."},{"issue":"44","key":"10.1016\/j.pnpbp.2026.111722_bb0090","doi-asserted-by":"crossref","first-page":"27646","DOI":"10.1073\/pnas.2003021117","article-title":"Cell type-specific lipid storage changes in Parkinson\u2019s disease patient brains are recapitulated by experimental glycolipid disturbance","volume":"117","author":"Brekk","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0095","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/BCJ20253062","article-title":"LRRK2-mediated mitochondrial dysfunction in Parkinson\u2019s disease","volume":"482","author":"Buck","year":"2025","journal-title":"Biochem. J."},{"issue":"16","key":"10.1016\/j.pnpbp.2026.111722_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168922","article-title":"Metabolic reprogramming of astrocytes in pathological conditions: implications for neurodegenerative diseases","volume":"25","author":"Cal\u00ec","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0105","series-title":"The Lancet Regional Health \u2013 Western Pacific 68","article-title":"Insights from a cross-sectional population-based study of 10,929 Australians living with Parkinson\u2019s disease: Risk factors, comorbidities, and sex differences","author":"Cao","year":"2026"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-024-00853-5","article-title":"Multiomics approach identifies dysregulated lipidomic and proteomic networks in Parkinson's disease patients mutated in TMEM175","volume":"11","author":"Carrillo","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13293-023-00487-x","article-title":"Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory-entorhinal-amygdaloid axis in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"14","author":"Cartas-Cejudo","year":"2023","journal-title":"Biol. Sex Differ."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tins.2009.01.006","article-title":"Calcium homeostasis, selective vulnerability and Parkinson\u2019s disease","volume":"32","author":"Chan","year":"2009","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mds.28826","article-title":"Plasma glutathione and prodromal Parkinson\u2019s disease probability","volume":"37","author":"Charisis","year":"2022","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-025-00467-8","article-title":"Parkinson's disease and glucose metabolism impairment","volume":"14","author":"Chen","year":"2025","journal-title":"Transl Neurodegener"},{"issue":"Pt 1","key":"10.1016\/j.pnpbp.2026.111722_bb0135","article-title":"Orchestrating AMPK\/mTOR signaling to initiate melittin-induced mitophagy: a neuroprotective strategy against Parkinson\u2019s disease","volume":"281","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"14","key":"10.1016\/j.pnpbp.2026.111722_bb0140","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400289R","article-title":"High-intensity interval training improves hypothalamic inflammation by suppressing HIF-1\u03b1 signaling in microglia of male C57BL\/6J mice","volume":"38","author":"Chen","year":"2024","journal-title":"FASEB J."},{"issue":"33","key":"10.1016\/j.pnpbp.2026.111722_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202400361","article-title":"NIR absorbing organic chromophores combination with NSAIDs for remodeling of the inflammatory microenvironment to amplify tumor ferroptosis-photothermal synergistic therapy","volume":"20","author":"Chen","year":"2024","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-021-02187-y","article-title":"Early glycolytic reprogramming controls microglial inflammatory activation","volume":"18","author":"Cheng","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0155","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s13311-021-01067-w","article-title":"Nutritional ketosis in Parkinson\u2019s disease - a review of remaining questions and insights","volume":"18","author":"Choi","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0160","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41593-022-01206-2","article-title":"Author correction: pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity","volume":"25","author":"Choi","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108373","article-title":"Molecular mechanisms of ferroptosis and their involvement in brain diseases","volume":"244","author":"Costa","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111722_bb0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41583-024-00812-2","article-title":"Key genes and convergent pathogenic mechanisms in Parkinson disease","volume":"25","author":"Coukos","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb0175","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948052","article-title":"Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response","volume":"21","author":"Court","year":"2020","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111722_bb0180","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","article-title":"LXR regulation of brain cholesterol: from development to disease","volume":"27","author":"Courtney","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110672","article-title":"Glucose metabolism impairment in Parkinson\u2019s disease","volume":"199","author":"Dai","year":"2023","journal-title":"Brain Res. Bull."},{"issue":"9\u201310","key":"10.1016\/j.pnpbp.2026.111722_bb0190","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10495-024-01977-y","article-title":"Mitophagy in health and disease. Molecular mechanisms, regulatory pathways, and therapeutic implications","volume":"29","author":"D\u2019Arcy","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0195","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbi.2023.07.023","article-title":"TSPO PET brain inflammation imaging: a transdiagnostic systematic review and meta-analysis of 156 case-control studies","volume":"113","author":"De Picker","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2020.102216","article-title":"Targeting mitochondrial calcium pathways as a potential treatment against Parkinson's disease","volume":"89","author":"Dey","year":"2020","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-023-00343-3","article-title":"Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis","volume":"12","author":"de Dios","year":"2023","journal-title":"Transl Neurodegener"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0210","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12264-023-01123-9","article-title":"Relationship between short-chain fatty acids and Parkinson\u2019s disease: a review from pathology to clinic","volume":"40","author":"Duan","year":"2024","journal-title":"Neurosci. Bull."},{"issue":"Pt 5","key":"10.1016\/j.pnpbp.2026.111722_bb0215","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the Bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases","volume":"17","author":"Fern\u00e1ndez-Calle","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0225","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.1620506114","article-title":"Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism","volume":"114","author":"Ferris","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111722_bb0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11306-024-02181-4","article-title":"Dopaminergic neuron metabolism: relevance for understanding Parkinson\u2019s disease","volume":"20","author":"Flores-Ponce","year":"2024","journal-title":"Metabolomics"},{"issue":"10423","key":"10.1016\/j.pnpbp.2026.111722_bb0235","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson's disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.31083\/j.fbl2701020","article-title":"Calpain activation and progression of inflammatory cycles in Parkinson\u2019s disease","volume":"27","author":"Gao","year":"2022","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0245","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0250","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.freeradbiomed.2026.01.023","article-title":"NRF2 at the crossroads of Parkinson\u2019s disease and aging: mechanistic insights and translational perspectives","volume":"246","author":"Garc\u00eda-Yag\u00fce","year":"2026","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111722_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123005","article-title":"Plasma metabolic disturbances in Parkinson\u2019s disease patients","volume":"10","author":"G\u0105tarek","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13024-024-00756-2","article-title":"\u0391-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease","volume":"19","author":"Geibl","year":"2024","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0265","doi-asserted-by":"crossref","first-page":"4784268","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in Parkinson\u2019s disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.plipres.2015.10.005","article-title":"Interaction of \u03b1-synuclein with biomembranes in Parkinson\u2019s disease--role of cardiolipin","volume":"61","author":"Ghio","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009921","article-title":"Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a drosophila model of Parkinson\u2019s disease","volume":"17","author":"Girard","year":"2021","journal-title":"PLoS Genet."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111722_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073995","article-title":"Neuroinflammation in neurodegenerative disorders: current knowledge and therapeutic implications","volume":"25","author":"Giri","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2024.102856","article-title":"NMDA receptor-mediated ca(2+) signaling: impact on cell cycle regulation and the development of neurodegenerative diseases and cancer","volume":"119","author":"Gonz\u00e1lez-Cota","year":"2024","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0290","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fnana.2010.00140","article-title":"Vulnerability of mesostriatal dopaminergic neurons in Parkinson\u2019s disease","volume":"4","author":"Gonz\u00e1lez-Hern\u00e1ndez","year":"2010","journal-title":"Front. Neuroanat."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111722_bb0295","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1007\/s12035-023-03530-5","article-title":"Metformin and Trehalose-modulated autophagy exerts a neurotherapeutic effect on Parkinson\u2019s disease","volume":"60","author":"Gopar-Cuevas","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111722_bb0300","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41581-023-00692-2","article-title":"The role of lysosomes in metabolic and autoimmune diseases","volume":"19","author":"Gros","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0305","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1038\/s41598-024-62910-6","article-title":"Myricetin mitigates motor disturbance and decreases neuronal ferroptosis in a rat model of Parkinson\u2019s disease","volume":"14","author":"Gu","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111722_bb0310","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41419-021-03952-w","article-title":"Nrf2 activation induces mitophagy and reverses Parkin\/Pink1 knock down-mediated neuronal and muscle degeneration phenotypes","volume":"12","author":"Gumeni","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-023-00600-z","article-title":"Translational molecular imaging and drug development in Parkinson's disease","volume":"18","author":"Haider","year":"2023","journal-title":"Mol Neurodegener"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0320","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1080\/15548627.2022.2139080","article-title":"PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models","volume":"19","author":"Han","year":"2023","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0325","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13024-017-0212-x","article-title":"Hexokinases link DJ-1 to the PINK1\/Parkin pathway","volume":"12","author":"Hauser","year":"2017","journal-title":"Mol Neurodegener"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111722_bb0330","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.cmet.2022.09.002","article-title":"Hypothalamic astrocytes control systemic glucose metabolism and energy balance","volume":"34","author":"Herrera Moro Chao","year":"2022","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0335","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/ars.2016.6711","article-title":"Paraquat induces peripheral myelin disruption and locomotor defects: crosstalk with LXR and Wnt pathways","volume":"27","author":"Hichor","year":"2017","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0340","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1007\/s00259-021-05325-z","article-title":"Multivariate radiomics models based on (18)F-FDG hybrid PET\/MRI for distinguishing between Parkinson\u2019s disease and multiple system atrophy","volume":"48","author":"Hu","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"14","key":"10.1016\/j.pnpbp.2026.111722_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146992","article-title":"Branched-chain amino acids in Parkinson\u2019s disease: molecular mechanisms and therapeutic potential","volume":"26","author":"Huang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102214","article-title":"The mechanism of cuproptosis in Parkinson\u2019s disease","volume":"95","author":"Huang","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0355","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","article-title":"TREM2 deficiency aggravates NLRP3 inflammasome activation and pyroptosis in MPTP-induced Parkinson\u2019s disease mice and LPS-induced BV2 cells","volume":"61","author":"Huang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115619","article-title":"Role of microglial metabolic reprogramming in Parkinson\u2019s disease","volume":"213","author":"Huang","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111722_bb0365","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1093\/brain\/awac313","article-title":"DJ-1 is an essential downstream mediator in PINK1\/parkin-dependent mitophagy","volume":"145","author":"Imberechts","year":"2022","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb0370","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neurobiolaging.2014.10.039","article-title":"Identification of candidate genes for Parkinson\u2019s disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls","volume":"36","author":"Infante","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111722_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.04.001","article-title":"Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity","volume":"177","author":"Ioannou","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb0380","doi-asserted-by":"crossref","DOI":"10.1007\/s11302-025-10114-6","article-title":"The potential role of adenosinergic pathway and methylxanthines in parkinson\u2019s disease: blowing in the wind or not","volume":"22","author":"Ismail","year":"2026","journal-title":"Purinergic Signal"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0385","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1038\/s41598-019-40979-8","article-title":"Probing membrane association of \u03b1-synuclein domains with VDAC nanopore reveals unexpected binding pattern","volume":"9","author":"Jacobs","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0390","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41531-023-00459-3","article-title":"Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by synj1","volume":"9","author":"Jacquemyn","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0395","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s12276-024-01198-y","article-title":"The Mst1\/2-BNIP3 axis is required for mitophagy induction and neuronal viability under mitochondrial stress","volume":"56","author":"Jeong","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.589582","article-title":"Lactate transporters mediate glia-neuron metabolic crosstalk in homeostasis and disease","volume":"14","author":"Jha","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0405","doi-asserted-by":"crossref","first-page":"8837893","DOI":"10.1155\/2020\/8837893","article-title":"Mitochondria-targeted antioxidants: a step towards disease treatment","volume":"2020","author":"Jiang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0410","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0415","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/ene.14470","article-title":"Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson\u2019s disease: review and meta-analysis","volume":"27","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0420","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s40478-024-01915-8","article-title":"BCKDK loss impairs mitochondrial complex i activity and drives alpha-synuclein aggregation in models of Parkinson\u2019s disease","volume":"12","author":"Jishi","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0425","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbi.2025.06.026","article-title":"Sex differences in neurological disorders: insights from ischemic stroke, Parkinson\u2019s disease, and multiple sclerosis","volume":"129","author":"Kaufhold","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"724","key":"10.1016\/j.pnpbp.2026.111722_bb0430","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add0499","article-title":"Enhanced mTORC1 signaling and protein synthesis in pathologic \u03b1-synuclein cellular and animal models of Parkinson\u2019s disease","volume":"15","author":"Khan","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb0435","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s12276-021-00562-6","article-title":"Effects of innate immune receptor stimulation on extracellular \u03b1-synuclein uptake and degradation by brain resident cells","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111722_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.08.027","article-title":"Lipid biosynthesis coordinates a mitochondrial-to-cytosolic stress response","volume":"166","author":"Kim","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2023.10.002","article-title":"Mitochondrial dysfunction in neurodegenerative disorders","volume":"21","author":"Klemmensen","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030683","article-title":"Association of cognitive deficit with glutamate and insulin signaling in a rat model of Parkinson\u2019s disease","volume":"11","author":"Knezovic","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0455","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12974-019-1648-4","article-title":"Monocarboxylate transporter 1 promotes classical microglial activation and pro-inflammatory effect via 6-phosphofructo-2-kinase\/fructose-2, 6-biphosphatase 3","volume":"16","author":"Kong","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111722_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072197","article-title":"Beneficial effects of exogenous ketogenic supplements on aging processes and age-related neurodegenerative diseases","volume":"13","author":"Kov\u00e1cs","year":"2021","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111722_bb0470","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1007\/s11010-025-05324-w","article-title":"The role of L-DOPA in neurological and neurodegenerative complications: a review","volume":"480","author":"Kulkarni","year":"2025","journal-title":"Mol. Cell. Biochem."},{"issue":"23","key":"10.1016\/j.pnpbp.2026.111722_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233736","article-title":"Levodopa-induced dyskinesia in Parkinson\u2019s disease: pathogenesis and emerging treatment strategies","volume":"11","author":"Kwon","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0480","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41420-023-01504-z","article-title":"The regulatory role of lipophagy in central nervous system diseases","volume":"9","author":"Lan","year":"2023","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0485","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-022-00555-7","article-title":"Crosstalk of organelles in Parkinson's disease - MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes","volume":"17","author":"Lang","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0490","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/scrt206","article-title":"CD70-CD27 ligation between neural stem cells and CD4+ T cells induces Fas-FasL-mediated T-cell death","volume":"4","author":"Lee","year":"2013","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0495","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","article-title":"Function and therapeutic value of astrocytes in neurological diseases","volume":"21","author":"Lee","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0500","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2020.07.017","article-title":"Lipid metabolism in astrocytic structure and function","volume":"112","author":"Lee","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb0505","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14411","article-title":"The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson\u2019s disease","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105605","article-title":"Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson\u2019s disease","volume":"163","author":"Li","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111722_bb0515","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.4103\/1673-5374.335143","article-title":"Role of exosomes in the pathogenesis of inflammation in Parkinson\u2019s disease","volume":"17","author":"Li","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0520","first-page":"261","article-title":"Visualizing dynamic performance of lipid droplets in a Parkinson\u2019s disease model via a smart photostable aggregation-induced emission","volume":"iScience 21","author":"Li","year":"2019","journal-title":"Probe"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111722_bb0525","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14913","article-title":"Hyperglycemia-induced sirt3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesis","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111722_bb0530","article-title":"SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2","volume":"5","author":"Lian","year":"2024","journal-title":"Cell Rep Med"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111722_bb0535","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1080\/15548627.2020.1850008","article-title":"Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK\/ERK signaling are found in aged mutant parkinsonian LRRK2(R1441G) mice","volume":"17","author":"Liu","year":"2021","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0540","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12264-024-01342-8","article-title":"Type 2 diabetes mellitus exacerbates pathological processes of Parkinson\u2019s disease: insights from signaling pathways mediated by insulin receptors","volume":"41","author":"Liu","year":"2025","journal-title":"Neurosci. Bull."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111722_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084148","article-title":"Biomarker of neuroinflammation in Parkinson\u2019s disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt B","key":"10.1016\/j.pnpbp.2026.111722_bb0550","article-title":"GLP-1 analogue liraglutide attenuates CIH-induced cognitive deficits by inhibiting oxidative stress, neuroinflammation, and apoptosis via the Nrf2\/HO-1 and MAPK\/NF-\u03baB signaling pathways","volume":"142","author":"Lv","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0555","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrn.2018.19","article-title":"Lactate in the brain: from metabolic end-product to signalling molecule","volume":"19","author":"Magistretti","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0560","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.635050","article-title":"Multi-electrode array analysis identifies complex dopamine responses and glucose sensing properties of substantia nigra neurons in mouse brain slices","volume":"13","author":"Mannal","year":"2021","journal-title":"Front Synaptic Neurosci"},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0570","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41419-023-06290-1","article-title":"Negative modulation of mitochondrial calcium uniporter complex protects neurons against ferroptosis","volume":"14","author":"Marmolejo-Garza","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0575","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13024-019-0332-6","article-title":"Impaired dopamine metabolism in Parkinson's disease pathogenesis","volume":"14","author":"Masato","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0580","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41531-023-00485-1","article-title":"DOPAL initiates \u03b1Synuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease","volume":"9","author":"Masato","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"Pt 1","key":"10.1016\/j.pnpbp.2026.111722_bb0585","article-title":"GLP1 secretagogue cinnamaldehyde upregulates GLP1\/PI3K\/AKT and nrf2 pathways to exert neuroprotection in a rotenone induced mouse model of Parkinson\u2019s disease","volume":"320","author":"Mathur","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111722_bb0590","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300003R","article-title":"Unsaturated fatty acids uniquely alter aggregation rate of \u03b1-synuclein and insulin and change the secondary structure and toxicity of amyloid aggregates formed in their presence","volume":"37","author":"Matveyenka","year":"2023","journal-title":"FASEB J."},{"issue":"33","key":"10.1016\/j.pnpbp.2026.111722_bb0595","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204619119","article-title":"Whole-brain neuronal MCT2 lactate transporter expression links metabolism to human brain structure and function","volume":"119","author":"Medel","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0600","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1080\/15548627.2023.2234797","article-title":"Tethering ATG16L1 or LC3 induces targeted autophagic degradation of protein aggregates and mitochondria","volume":"19","author":"Mei","year":"2023","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0605","doi-asserted-by":"crossref","DOI":"10.1002\/biof.2149","article-title":"Agmatine suppresses glycolysis via the PI3K\/Akt\/mTOR\/HIF-1\u03b1 signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide","volume":"51","author":"Milosevic","year":"2025","journal-title":"Biofactors"},{"issue":"19","key":"10.1016\/j.pnpbp.2026.111722_bb0610","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911394","article-title":"Oxidative stress and mitochondrial complex i dysfunction correlate with neurodegeneration in an \u03b1-synucleinopathy animal model","volume":"23","author":"Morales-Mart\u00ednez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111722_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093301","article-title":"Lipids: key players that modulate \u03b1-synuclein toxicity and neurodegeneration in Parkinson\u2019s disease","volume":"21","author":"Mori","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111722_bb0620","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.4103\/NRR.NRR-D-23-01624","article-title":"Dysfunction of synaptic endocytic trafficking in Parkinson\u2019s disease","volume":"19","author":"Ng","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0625","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00259-024-06881-w","article-title":"Spatial-temporal dynamic evolution of lewy body dementia by metabolic PET imaging","volume":"52","author":"Niu","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101979","article-title":"Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease","volume":"89","author":"Nowell","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0635","doi-asserted-by":"crossref","DOI":"10.3390\/metabo15030208","article-title":"Metabolomics in Parkinson\u2019s disease and correlation with disease state","volume":"15","author":"Ostrakhovitch","year":"2025","journal-title":"Metabolites"},{"issue":"18","key":"10.1016\/j.pnpbp.2026.111722_bb0640","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.03.002","article-title":"The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: potential targets for neurotherapeutics","volume":"161","author":"Pajarillo","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175733","article-title":"Glutamate dehydrogenase: potential therapeutic targets for neurodegenerative disease","volume":"950","author":"Pan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0655","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-022-00281-6","article-title":"LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson\u2019s disease","volume":"11","author":"Pang","year":"2022","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0660","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12929-023-00961-z","article-title":"Neuroprotective effects of osmotin in Parkinson\u2019s disease-associated pathology via the AdipoR1\/MAPK\/AMPK\/mTOR signaling pathways","volume":"30","author":"Park","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"30","key":"10.1016\/j.pnpbp.2026.111722_bb0665","doi-asserted-by":"crossref","first-page":"15226","DOI":"10.1073\/pnas.1821409116","article-title":"\u0391-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson\u2019s disease patients","volume":"116","author":"Paslawski","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111722_bb0670","article-title":"Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111722_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101508","article-title":"Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson\u2019s disease: roads to biomarker discovery","volume":"11","author":"Picca","year":"2021","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111722_bb0680","article-title":"Neuroinflammation and mitochondrial dysfunction in Parkinson\u2019s disease: connecting neuroimaging with pathophysiology","volume":"12","author":"Pizarro-Galleguillos","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0685","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5371","article-title":"Mitochondrial dysfunction in chronic neuroinflammatory diseases (review)","volume":"53","author":"Qin","year":"2024","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0690","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","article-title":"PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation","volume":"8","author":"Quinn","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111722_bb0695","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41418-018-0219-z","article-title":"PINK1-dependent mitophagy is driven by the UPS and can occur independently of LC3 conversion","volume":"26","author":"Rakovic","year":"2019","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111722_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094956","article-title":"Epigenetic regulation of neuroinflammation in Parkinson\u2019s disease","volume":"22","author":"Rasheed","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0705","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/brain\/awaa019","article-title":"Network degeneration in Parkinson\u2019s disease: multimodal imaging of nigro-striato-cortical dysfunction","volume":"143","author":"Ruppert","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0710","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","article-title":"Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease","volume":"147","author":"Rutledge","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111722_bb0715","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/mds.29161","article-title":"Lewy body disease primate model with \u03b1-synuclein propagation from the olfactory bulb","volume":"37","author":"Sawamura","year":"2022","journal-title":"Mov. Disord."},{"issue":"18","key":"10.1016\/j.pnpbp.2026.111722_bb0720","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.neuron.2024.06.029","article-title":"Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes","volume":"112","author":"Scheiblich","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0725","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41531-022-00392-x","article-title":"Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes","volume":"8","author":"Schr\u00f6ter","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111722_bb0730","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4103\/1673-5374.335690","article-title":"Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity","volume":"17","author":"Segura-Aguilar","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"15","key":"10.1016\/j.pnpbp.2026.111722_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157498","article-title":"The redox revolution in brain medicine: targeting oxidative stress with AI, multi-omics and mitochondrial therapies for the precision eradication of neurodegeneration","volume":"26","author":"\u0218erban","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111722_bb0740","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0745","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/sj.jcbfm.9600521","article-title":"Supply and demand in cerebral energy metabolism: the role of nutrient transporters","volume":"27","author":"Simpson","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0750","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","article-title":"Glutathione metabolism and Parkinson\u2019s disease","volume":"62","author":"Smeyne","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111722_bb0755","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1021\/acsptsci.4c00586","article-title":"Hyperglycemia-driven insulin signaling defects promote Parkinson\u2019s disease-like pathology in mice","volume":"7","author":"Soni","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"13","key":"10.1016\/j.pnpbp.2026.111722_bb0760","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMe2401743","article-title":"GLP-1, parkinson\u2019s disease, and neuroprotection","volume":"390","author":"Standaert","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0765","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/brain\/awab373","article-title":"Dopamine neurons exhibit emergent glutamatergic identity in Parkinson's disease","volume":"145","author":"Steinkellner","year":"2022","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb0770","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0775","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111722_bb0780","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1080\/15548627.2020.1822097","article-title":"Mitophagy in degenerative joint diseases","volume":"17","author":"Sun","year":"2021","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb0785","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ceca.2009.12.003","article-title":"Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease","volume":"47","author":"Surmeier","year":"2010","journal-title":"Cell Calcium"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0790","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/mds.28932","article-title":"GBA and APOE impact cognitive decline in Parkinson\u2019s disease: a 10-year population-based study","volume":"37","author":"Szwedo","year":"2022","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0795","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00018-024-05436-4","article-title":"Protein tyrosine phosphatase receptor type o serves as a key regulator of insulin resistance-induced \u03b1-synuclein aggregation in Parkinson\u2019s disease","volume":"81","author":"Tan","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102545","article-title":"The role of sirtuin 1 in ageing and neurodegenerative disease: a molecular perspective","volume":"102","author":"Thapa","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0805","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/s41467-021-21984-w","article-title":"Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPs","volume":"12","author":"Todkar","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107601","article-title":"Srebf1 controls midbrain dopaminergic neurogenesis","volume":"31","author":"Toledo","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0815","doi-asserted-by":"crossref","first-page":"15583","DOI":"10.1038\/s41598-020-72638-8","article-title":"Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models","volume":"10","author":"Trabjerg","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0820","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41531-023-00450-y","article-title":"Inhibition of carnitine palmitoyl-transferase 1 is a potential target in a mouse model of Parkinson's disease","volume":"9","author":"Trabjerg","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111722_bb0825","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/brain\/awac464","article-title":"Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1\/PRKN-linked Parkinson's disease","volume":"146","author":"Trinh","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0830","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00018-024-05373-2","article-title":"RXR nuclear receptor signaling modulates lipid metabolism and triggers lysosomal clearance of alpha-synuclein in neuronal models of synucleinopathy","volume":"81","author":"Tripathi","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111722_bb0835","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11306-019-1554-x","article-title":"A metabolomic signature of treated and drug-na\u00efve patients with Parkinson\u2019s disease: a pilot study","volume":"15","author":"Troisi","year":"2019","journal-title":"Metabolomics"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111722_bb0840","first-page":"1356","article-title":"Mitochondrial complex I as a pathologic and therapeutic target for Parkinson\u2019s disease","volume":"14","author":"Tryphena","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0845","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1038\/s41467-022-34080-4","article-title":"Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation","volume":"13","author":"Tu","year":"2022","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.pnpbp.2026.111722_bb0850","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137144","article-title":"An altered sphingolipid profile as a risk factor for progressive neurodegeneration in long-chain 3-Hydroxyacyl-CoA deficiency (LCHADD)","volume":"23","author":"Tucci","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0855","article-title":"The possible impact of montelukast in parkinson\u2019s disease: a substantial contribution","volume":"16","author":"Turkistani","year":"2026","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0860","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010014","article-title":"Zonisamide administration improves fatty acid \u03b2-oxidation in Parkinson\u2019s disease","volume":"8","author":"Ueno","year":"2018","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0865","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0870","doi-asserted-by":"crossref","first-page":"2537991","DOI":"10.1080\/21688370.2025.2537991","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease: mechanisms, biomarkers, and therapeutic strategies","volume":"14","author":"Usha Kiran","year":"2026","journal-title":"Tissue Barriers"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111722_bb0875","doi-asserted-by":"crossref","DOI":"10.3390\/biom10101437","article-title":"The dichotomous role of inflammation in the CNS: a mitochondrial point of view","volume":"10","author":"Vezzani","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0880","article-title":"Mitochondrial behavior in axon degeneration and regeneration","volume":"13","author":"Wang","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0885","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41420-024-02273-z","article-title":"17\u03b2-estradiol alleviated ferroptotic neuroinflammation by suppressing ATF4 in mouse model of Parkinson\u2019s disease","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0890","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41531-025-01013-z","article-title":"Neural basis of dysexecutive and visuospatial impairments in Parkinson\u2019s disease with MCI: a task-based fNIRS study","volume":"11","author":"Wang","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0895","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tins.2024.01.002","article-title":"Protein-protein interactions regulating \u03b1-synuclein pathology","volume":"47","author":"Wang","year":"2024","journal-title":"Trends Neurosci."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111722_bb0900","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1007\/s12035-021-02463-1","article-title":"TLR2 potentiates SR-marco-mediated neuroinflammation by interacting with the SRCR domain","volume":"58","author":"Wang","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0905","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12974-024-03072-0","article-title":"Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson\u2019s disease through Mfn2-cGAS signaling","volume":"21","author":"Wang","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0910","doi-asserted-by":"crossref","first-page":"1551404","DOI":"10.3389\/fnagi.2025.1551404","article-title":"The mechanism of electroacupuncture-mediated improvement in Parkinson\u2019s disease by inhibiting ferroptosis through activating the Nrf2\/GPX4 signal pathway","volume":"17","author":"Wang","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111722_bb0915","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s11427-020-1756-9","article-title":"\u0391-Synuclein aggregation and transmission in Parkinson\u2019s disease: a link to mitochondria and lysosome","volume":"63","author":"Wang","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"29","key":"10.1016\/j.pnpbp.2026.111722_bb0920","doi-asserted-by":"crossref","first-page":"32901","DOI":"10.1021\/acsami.2c06981","article-title":"Polydopamine-based nanocomposite as a biomimetic antioxidant with a variety of enzymatic activities for Parkinson\u2019s disease","volume":"14","author":"Wang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111722_bb0925","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neuron.2023.11.002","article-title":"Mesoaccumbal glutamate neurons drive reward via glutamate release but aversion via dopamine co-release","volume":"112","author":"Warlow","year":"2024","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0930","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042009","article-title":"Parkinson\u2019s disease: cells succumbing to lifelong dopamine-related oxidative stress and other bioenergetic challenges","volume":"25","author":"Watanabe","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0935","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2026.111722_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177104","article-title":"Biochanin a inhibits excitotoxicity-triggered ferroptosis in hippocampal neurons","volume":"985","author":"Won","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111722_bb0945","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/glia.24259","article-title":"Astrocyte-specific loss of lactoferrin influences neuronal structure and function by interfering with cholesterol synthesis","volume":"70","author":"Xu","year":"2022","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb0950","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/1673-5374.374142","article-title":"Lactate metabolism in neurodegenerative diseases","volume":"19","author":"Yang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105290","article-title":"Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system","volume":"152","author":"Yang","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155230","article-title":"Echinacoside exerts neuroprotection via suppressing microglial \u03b1-synuclein\/TLR2\/NF-\u03baB\/NLRP3 axis in parkinsonian models","volume":"123","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb0965","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15548627.2020.1725377","article-title":"Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles","volume":"17","author":"Yao","year":"2021","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111722_bb0970","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/jnc.14587","article-title":"Action potential and calcium dependence of tonic somatodendritic dopamine release in the substantia nigra pars compacta","volume":"148","author":"Yee","year":"2019","journal-title":"J. Neurochem."},{"issue":"23","key":"10.1016\/j.pnpbp.2026.111722_bb0975","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314753","article-title":"Pathogenesis of \u03b1-Synuclein in parkinson\u2019s disease: from a neuron-glia crosstalk perspective","volume":"23","author":"Yi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 2","key":"10.1016\/j.pnpbp.2026.111722_bb0980","article-title":"TREM2 signaling in Parkinson\u2019s disease: regulation of microglial function and \u03b1-synuclein pathology","volume":"143","author":"Yin","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111722_bb0985","article-title":"Association of striatal dopamine depletion and brain metabolism changes with motor and cognitive deficits in patients with Parkinson disease","volume":"103","author":"Yoo","year":"2024","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb0990","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cmet.2021.03.025","article-title":"The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine","volume":"33","author":"Yu","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.pnpbp.2026.111722_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102032","article-title":"Metabolic reprogramming and polarization of microglia in Parkinson\u2019s disease: role of inflammasome and iron","volume":"90","author":"Yu","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.pnpbp.2026.111722_bb1000","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mito.2022.02.003","article-title":"Fighting Parkinson\u2019s disease: the return of the mitochondria","volume":"64","author":"Zambrano","year":"2022","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111722_bb1005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4103\/1673-5374.355815","article-title":"Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson\u2019s disease","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111722_bb1010","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb1015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41531-022-00312-z","article-title":"Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson's disease","volume":"8","author":"Zhang","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"18","key":"10.1016\/j.pnpbp.2026.111722_bb1020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184391","article-title":"Roles of glutamate receptors in Parkinson\u2019s disease","volume":"20","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111722_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167953","article-title":"The interplay between lipid droplets and Parkinson\u2019s disease","volume":"1871","author":"Zhao","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111722_bb1030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jpha.2022.11.006","article-title":"PKM2-mediated neuronal hyperglycolysis enhances the risk of Parkinson's disease in diabetic rats","volume":"13","author":"Zhao","year":"2023","journal-title":"J Pharm Anal"},{"issue":"22","key":"10.1016\/j.pnpbp.2026.111722_bb1035","article-title":"Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of Parkinson\u2019s disease","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111722_bb1040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40035-023-00378-6","article-title":"Role of dopamine in the pathophysiology of Parkinson's disease","volume":"12","author":"Zhou","year":"2023","journal-title":"Transl Neurodegener"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111722_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110823","article-title":"Divergent properties and independent regulation of striatal dopamine and GABA co-transmission","volume":"39","author":"Zych","year":"2022","journal-title":"Cell Rep."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:28:00Z","timestamp":1785205680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":209,"alternative-id":["S0278584626001193"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111722","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Energy metabolic failure drives the selective degeneration of dopaminergic neurons in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111722"}}